VP, Head of Translational Clinical Sciences
Biotech
New Haven, Connecticut
Mark Ma is the VP, Head of Translational Clinical Sciences of Rallybio. Prior to Rallybio, Mark had taken several leadership roles at Alexion/AstraZeneca Pharmaceuticals and Amgen Inc, including the head of Bioanalytical and Biomarker Development and the Director of large Molecule Bioanalytical Science. Currently, Mark serves as the co-chair of Bioanalytical Community, AAPS 2021-2022.
Supporting Rare Disease Drug Development and Use of Biomarkers: Ravulizumab Case Study
Monday, October 23, 2023
9:00 AM – 9:30 AM ET
Use of AI to Guide Immunoassay Development
Monday, October 23, 2023
3:15 PM – 3:30 PM ET
Wednesday, October 25, 2023
1:30 PM – 2:30 PM ET